Estancia La Jolla Hotel
La Jolla, California


SYMPOSIUM INFORMATION

>General Information
>Faculty
>Program/Schedule
>Accreditation
>Registration
>Hotel Reservations

 

Sponsored by:
UCSD School of Medicine
UCSD Sulpizio Cardiovascular Center

PROGRAM / SCHEDULE

7:00 – 8:00am Registration/Coffee

7:10-8:10am Breakfast - Pacifica Ballroom Foyer

7:10-8:10am Additional Session* (Breakfast Lecture)- Pacifica Ballroom

8:10-8:15am
Introductions, Welcome and Overview: Drs. Alan Maisel, Lori Daniels, David Brenner and Etisham Mahmud

Session I:
Ischemia
Alan Maisel, MD, Moderator

8:15-8:30am
The Universal Definition of an MI – Let’s Boil this Down to Clinical Practice
Allan S. Jaffe, MD

8:30-8:45am
Presenting with Chest Pain - What is the Quickest we can Rule Out, Who Goes Home vs. Observation Unit
W. Frank Peacock, MD

8:45-9:30am
Panel Discussion
Type II MI- How to Diagnose, What Does it Mean Regarding RX, Admission and Prognosis
Alan Maisel, MD (Presenter)
Drs. Daniels, Jaffe, DiFilippi and Peacock (Discussants)

9:30–9:50am Coffee Break/Visit Exhibits

Session II:
What’s Hot Out There in Biomarkers and Heart Failure
Lori Daniels, MD, Moderator

9:50-10:05am
ST2 and Therapeutic Guidance
Alan Maisel, MD

10:05-10:20am
Natriuretic Peptides and Valsarten/Sacubitril
Lori B. Daniels, MD

10:20-10:35am
K Binding to Improve Guideline Directed Treatment
Lori B. Daniels, MD

10:35-10:50am
Acute Heart Failure; What’s New?
Uri Elkayam, MD

10:50–11:05am
Procalcitonin for Guiding Antibiotic RX Therapy in Heart Failure
Sean-Xavier Neath, MD, PhD

11:05-11:20am
Ivabridine to Control the Biomarker of Heart Rate
Inder Anand, MD, PhD

11:20-11:35am
Issues with Anticoagulation, Afib and Heart Failure - No More INR?
Daniel Blanchard, MD

11:35-11:50pm
Controlling O2 Sat in SDB
Alan Maisel, MD

11:50-12:05pm
Cardio-Renal Biomarkers and Heart Failure
Nicholas Wettersten, MD

12:05–1:35 Lunch

12:05–1:35 Additional Session** (Lunch Lecture)

Session III:
Special Lectures
Alan Maisel, MD, Moderator

1:35- 1:55pm
Early Results on the CIAO Longevity Study
Nicholas Schork, MD

1:55-2:15pm
Important Distinctions in Heart Failure Guidelines: US versus Europe
Greg Fonarow, MD

2:15-2:35pm
Emerging Biomarkers for Assessment of Acute Heart Failure and Renal Function
Allan S. Jaffe, MD

2:35-2:55pm
When to Use CardioMems in Heart Failure - Pulmonary Pressure as a
Dynamic Biomarker
J. Thomas Heywood, MD

2:55-3:15pm
Wearables and Implantables for Our Patients: Life Vests, Loop Recorders, Activity Monitors, Etc.
Pam Taub, MD

3:15-3:35pm Coffee Break/Visit Exhibits

3:35-3:55pm
Next Generation Point-of-Care Testing for Cardiac Markers:
Have we Caught Up with the Central Lab?
Alan Wu, PhD

Session IV:
BEST is LAST
Lori B. Daniels, MD, Moderator

3:55-4:15pm
Best Lipid Treatments
Pam Taub, MD

4:15-4:35pm
Pulmonary Hypertension RX
Eric Adler, MD

4:35-4:55pm
The Future of Biomarkers
Christopher deFilippi

4:55-5:00pm
Recap: Concluding Remarks
Alan Maisel, MD and Lori B. Daniels, MD

ADDITIONAL SESSIONS AVAILABLE:
Please note, the following sessions are not part of the accredited educational activity (credit is not offered for attending).
Optional to attend.

*7:10-8:10am
Treating Thrombosis and Reducing Thrombotic Risk for Patients with Non-Valvular Atrial Fibrillation and Heart Failure -
Uri Elkayam, MD
Pacifica Ballroom

**12:05-1:35pm
Putting Guidelines into Practice: New Recommendations for Optimal Treatment of Heart Failure with Reduced Ejection Fraction (HFrEF)
Gregg C Fonarow, MD, FAHA, FACC, FHFSA
Pacifica Ballroom